Literature DB >> 16086588

Substrate discrimination by the human GTP fucose pyrophosphorylase.

Stephen Quirk1, Katherine L Seley.   

Abstract

GTP-l-fucose pyrophosphorylase (GFPP, E. C. 2.7.7.30) catalyzes the reversible condensation of guanosine triphosphate and beta-l-fucose-1-phosphate to form the nucleotide-sugar GDP-beta-l-fucose. The enzyme functions primarily in the mammalian liver and kidney to salvage free l-fucose during the breakdown of glycolipids and glycoproteins. The mechanism by which this protein discriminates between substrate and nonsubstrate molecules has been elucidated for the first time in this study. The ability of GFPP to form nucleotide-sugars from a series of base-, ribose-, phosphate-, and hexose-modified precursor molecules has revealed that the enzyme active site senses a series of substrate substituents that drive substrate/nonsubstrate discrimination. These substituents alter the ability of the precursor molecule to interact with the enzyme, as measured by either changes in the Michaelis constant, K(m), the binding affinity, K(a), or through changes in enzymatic turnover, k(cat). In this work, the combined substrate binding and enzyme analysis has revealed that the nature of the purine base is the major determinant in substrate specificity, followed by the nature of the hexose-1-P, and finally by the ribose moiety. Binding is enthalpy-driven and does not involve proton transfer. For the majority of nucleotide-sugar analogues, binding to GFPP is entropically unfavorable; however, surprisingly, a few of the substrate analogues tested bind to GFPP with a favorable entropic term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086588     DOI: 10.1021/bi0503605

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Crystallization and preliminary X-ray characterization of the Vitis vinifera fucokinase:GDP-fucose pyrophosphorylase.

Authors:  Stephen Quirk
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-08-31

2.  Carbocyclic 5'-nor "reverse" fleximers. Design, synthesis, and preliminary biological activity.

Authors:  Sarah C Zimmermann; Joshua M Sadler; Graciela Andrei; Robert Snoeck; Jan Balzarini; Katherine L Seley-Radtke
Journal:  Medchemcomm       Date:  2011-07-01       Impact factor: 3.597

3.  Synthesis and biological evaluation of a series of thieno-expanded tricyclic purine 2'-deoxy nucleoside analogues.

Authors:  Orrette R Wauchope; Cameron Johnson; Pasupathy Krishnamoorthy; Graciela Andrei; Robert Snoeck; Jan Balzarini; Katherine L Seley-Radtke
Journal:  Bioorg Med Chem       Date:  2012-03-12       Impact factor: 3.641

4.  Purification, crystallization and preliminary X-ray characterization of the human GTP fucose pyrophosphorylase.

Authors:  Stephen Quirk; Katherine L Seley-Radtke
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-25

5.  Synthetic Routes to a Series of Proximal and Distal 2'-Deoxy Fleximers.

Authors:  Orrette R Wauchope; Melvin Velasquez; Katherine Seley-Radtke
Journal:  Synthesis (Stuttg)       Date:  2012       Impact factor: 3.157

6.  Mechanistic studies in the synthesis of a series of thieno-expanded xanthosine and guanosine nucleosides.

Authors:  Zhibo Zhang; Orrette R Wauchope; Katherine L Seley-Radtke
Journal:  Tetrahedron       Date:  2008-11-24       Impact factor: 2.457

7.  "Reverse" carbocyclic fleximers: synthesis of a new class of adenosine deaminase inhibitors.

Authors:  Sarah C Zimmermann; Joshua M Sadler; Peter I O'Daniel; Nathaniel T Kim; Katherine L Seley-Radtke
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2013       Impact factor: 1.381

8.  Enzymatic activity of alpha-L-fucosidase and L-fucokinase across vertebrate animal species.

Authors:  Bradley J Honas; Urlene M Glassman; Thomas J Wiese
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2009-04-24       Impact factor: 2.231

9.  "Reverse fleximers": introduction of a series of 5-substituted carbocyclic uridine analogues.

Authors:  Joshua M Sadler; Olubukola Ojewoye; Katherine L Seley-Radtke
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2008

10.  Metabolic labeling of fucosylated glycans in developing zebrafish.

Authors:  Karen W Dehnert; Brendan J Beahm; Thinh T Huynh; Jeremy M Baskin; Scott T Laughlin; Wei Wang; Peng Wu; Sharon L Amacher; Carolyn R Bertozzi
Journal:  ACS Chem Biol       Date:  2011-04-05       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.